Fig. 1: The effect of CBD treatment on core cognitive and psychopathological outcome measures. | Neuropsychopharmacology

Fig. 1: The effect of CBD treatment on core cognitive and psychopathological outcome measures.

From: Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial

Fig. 1

A Delayed verbal learning on the HVLT-R; B Positive psychosis symptoms measured by the PANSS-Positive Subscale; C Negative psychosis symptoms measured by the PANSS-Negative Subscale; D Participant rated level of intoxication measured with a visual analogue scale for ‘Feel Drug Effect’. Blue: CBD pre-treatment arm; Pink: Placebo pre-treatment arm. Shaded areas in violin plots (1A-C) represent distribution density. In Fig. 1D, the shaded areas represent 95% confidence intervals. **p = 0.01 ***p = 0.001.

Back to article page